Medscape

The biggest misconception regarding biosimilars is that they are so different from the originator that you cannot trust them, says […]

Despite some remaining challenges, biologic therapy continues to revolutionize the care of people with psoriasis, atopic dermatitis, and many other

SIGLEC‑1 expression correlates with disease activity in patients with lupus erythematosus during type I interferon blockade by anifrolumab. Medscape Medical

Persistent inflammation may influence neurodegeneration through microglial activation, yet evidence remains hypothesis driven. Medscape News Europe

Adalimumab and tocilizumab perform similarly in controlling inflammation while reducing the use of corticosteroids at week 16 in patients with

The ACA banned discriminating against patients with pre-existing conditions. So insurers started targeting their doctors instead. Dr Mattie Feldman discusses

In the first of a series of interviews with rheumatologists who transitioned from being employed to being an employer, Dr

Higher serum levels of interferon alfa, but not interferon gamma, are tied to worse disease activity in patients with rheumatoid

Vunakizumab, an interleukin-17 inhibitor, shows improved efficacy over placebo in treating active psoriatic arthritis at week 12, with mild or

Duloxetine 120 mg offers the greatest economic value for treating moderate-to-severe fibromyalgia, followed by pregabalin 450 mg, and provides greater

Higher protein intake may improve short-term hip bone strength during weight loss in older adults with overweight or obesity but

Long-term exposure to air pollution is tied to an increased risk of developing rheumatoid arthritis in older adults, especially among

Results from the phase 2 LILAC study are key in gaining this FDA designation. Medscape Medical News

Rheumatologists share how they are using AI platforms for clinical documentation, reducing EHR time, streamlining workflows, assisting with decision-making, and

AstraZeneca said on Tuesday that the U.S. health regulator had rejected its application for an easier-to-use version of ‌lupus therapy

In patients with ANCA-associated vasculitis, those positive for antimyeloperoxidase antibodies have a higher risk for adverse cardiovascular events than those

Rituximab is linked to lower risks for renal complications than cyclophosphamide in adult patients with immunoglobulin A vasculitis. Medscape Medical

A real-world cohort study finds that denosumab use is linked to a lower risk for incident knee osteoarthritis in adults

CHMP is reviewing avacopan, a drug authorized in the EU for treating adults with severe, active granulomatosis with polyangiitis or

Physicians surveyed by Medscape told how protected they feel from assaults and thefts at the medical offices or hospitals where

Over 10 years, nearly 13% of patients with seronegative rheumatoid arthritis receive a new diagnosis, most often spondyloarthritis, and over

Timely antiresorptive therapy post-osteoanabolic treatment is recommended, with less than one third of patients receiving it within 3 months. Medscape

In a real-world study, patients with psoriatic disease treated with an IL-17 targeted biologic and a GLP-1 agonist experienced improvements

Mycophenolate mofetil shows similar disease control to methotrexate in children with juvenile localized scleroderma, with significantly fewer adverse effects. Medscape

The striking benefits achieved with emerging treatment options for recalcitrant connective tissue diseases offer the potential to avoid disfiguring lesions

A cohort study finds the risk for acne in patients on JAK inhibitors for atopic dermatitis was about 2.5 times

Integrating patient-reported outcomes with passive smartphone data reveals associations of altered mobility and texting behaviors with rheumatoid arthritis flares, showing